openPR Logo
Press release

Atipamezole Market 2023 | Pfizer Inc., Orion Corp., Alvetra & Werfft GmbH, CP Pharmaceuticals Ltd. and Others are Top Key Players

10-25-2018 03:04 PM CET | Health & Medicine

Press release from: Allied Market Research

Atipamezole Market

Atipamezole Market

Atipamezole is a synthetic alpha 2 adrenergic receptor antagonist drug, which reverses the effects of sedative and analgesic drugs such as medetomidine, xylazine, amitraz, and detomidine among others, in animals. In addition, it is used to treat amitraz and imidazoline decongestants toxicity in animals.

Reduction in sedative time of animals shortens the in-clinic stay, saves the time of the staff, reduces hospitalization costs, and reduces revisits of the animal owner. Furthermore, the rising pet ownership and increasing healthcare expenditure on animals are anticipated to fuel the market growth. However, adverse effects of atipamezole and stringent government regulations associated with the safety and efficacy of atipamezole is anticipated to hinder the market growth. For instance, atipamezole is not approved for use in cats in the U.S. Ongoing R&D activities on atipamezole is anticipated to provide opportunities for the market growth.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/3352

The market is segmented on the basis of application, route of administration, and geography. Based on application, the market is divided into anti-sedative and others (anti-analgesic and amitraz toxicity). By route of administration, the market is segmented into intravenous, intramuscular, and others (subcutaneous and intraperitoneal). Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits:

• The study provides an in-depth analysis of the global atipamezole market with current trends and future estimations to elucidate investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
• The report provides a quantitative analysis to help stakeholders capitalize on prevailing market opportunities from (2017-2023) in terms of value.
• Extensive analysis of different segments helps understand various products of the market.
• Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/3352

Atipamezole Market Key Segment:

By Application

• Anti-Sedative
• Others

By Route of Administration

• Intravenous
• Intramuscular
• Others

By Geography

• North America

o U.S.
o Canada
o Mexico

• Europe

o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe

• Asia-Pacific

o Japan
o China
o India
o Rest of Asia-Pacific

• LAMEA

o Latin America
o The Middle East
o Africa

List of players profiled in the report

• Pfizer Inc.
• Orion Corporation
• Alvetra & Werfft GmbH
• CP Pharmaceuticals Ltd.
• Sogeval Laboratories, Inc.
• VetPharm, Inc.
• Ceva Sant Animale S.A.
• Dr. E. Graeub AG
• A x ience SAS
• Eli Lilly and Company

For More Details on this report visit @ https://www.alliedmarketresearch.com/atipamezole-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atipamezole Market 2023 | Pfizer Inc., Orion Corp., Alvetra & Werfft GmbH, CP Pharmaceuticals Ltd. and Others are Top Key Players here

News-ID: 1329112 • Views:

More Releases from Allied Market Research

Home Exercise Bike Market is expected to witness robust Compound Annual Growth Rate (CAGR) progress of 8.7% from 2021 to 2027.
Home Exercise Bike Market is expected to witness robust Compound Annual Growth R …
According to a new report published by Allied Market Research, titled, "Home Exercise Bike Market by Type, and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," The global home exercise bike market size was valued at $1,213.5 million in 2019, and is projected to reach $2,335.2 million by 2027, registering a CAGR of 8.7% from 2021 to 2027. The recumbent segment is expected to retain its dominant position, in terms
Rapidly expanding entertainment products industry is set to drive the growth of the $103.8 billion Toys market ; Ravensburger AG, Tomy Company, Ltd, Vtech Holdings, and Thames & Kosmos.
Rapidly expanding entertainment products industry is set to drive the growth of …
According to a new report published by Allied Market Research, titled, "Toys Market by Product Type, Age Group and Sales Channel: Opportunity Analysis and Industry Forecast, 2021-2027," the toys market size was $92.2 billion in 2019, and is projected reach $103.8 billion by 2027, registering a CAGR of 2.5% from 2021 to 2027. The increase in number of games bars, cafes and family entertainment centers worldwide is boosting the demand for
Global Home Beer Brewing Machine Market is expected to reach $25.4 million by the year 2030, as projected by Allied Market Research.
Global Home Beer Brewing Machine Market is expected to reach $25.4 million by th …
According to a new report published by Allied Market Research, titled, "home beer brewing machine market by product type, mechanism, and distribution channel: global opportunity analysis and industry forecast, 2021-2030," The global home beer brewing machine market size was valued at $19.1 million in 2020, and is projected to reach $25.4 million by 2030, registering a CAGR of 3.0% from 2021 to 2030. Request a report sample to gain comprehensive insights
Hospitality Robots Market is forecasted to grow at a Compound Annual Growth Rate (CAGR) of 25.5% through the year 2030, according to Allied Market Research.
Hospitality Robots Market is forecasted to grow at a Compound Annual Growth Rate …
According to a new report published by Allied Market Research, titled, "Hospitality Robots Market by Type, End User, Sales Channel and Region: Global Opportunity Analysis and Industry Forecast, 2021-2030," The global hospitality robots market size is expected to reach $3,083 million by 2030 at a CAGR of 25.5% from 2021 to 2030. Hospitality Robots Market by Type (Front Desk Robots, Delivery Robots, Cleaning Robots and Others) and end user (Hotels,

All 5 Releases


More Releases for Atipamezole

Atipamezole Market Size to Expand at the CAGR of 1% during the Forecast Period 2 …
Atipamezole Market: Introduction According to the report, the global atipamezole market was valued at US$ 60 Mn in 2019. It is projected to expand at a CAGR of ~1% from 2020 to 2030. Atipamezole is a specific α2-antagonist that was developed to reverse the actions of medetomidine and has marketing authorization for dogs and cats. Medetomidine and antagonism with atipamezole is, presently widely utilized in small animal practice. The reduction in
Insights on the Atipamezole Market to 2027 | Industry Statistics, Emerging Deman …
The global atipamezole market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Atipamezoles is a synthetic ?? adrenergic receptor antagonist. It is an anti-sedative drug that is indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs. The major factor for the growth of the market is the rising adoption of pets. According to the APPA National Pet Owners
Atipamezole Market Size 2021 | Incredible Possibilities, Growth, Trend, Opportun …
Reduction in sedative time of animals shortens the in-clinic stay, saves the time of the staff, reduces hospitalization costs, and reduces revisits of the animal owner. Furthermore, the rising pet ownership and increasing healthcare expenditure on animals are anticipated to fuel the market growth. However, adverse effects of atipamezole and stringent government regulations associated with the safety and efficacy of atipamezole is anticipated to hinder the market growth. For instance,
Atipamezole Market - Technological Advancement Facilitating Market Growth : Incl …
Overview of Atipamezole Market A comprehensive evaluation of the Atipamezole Market has been presented in the report for the forecasted period 2019 to 2025. In order to get a deep insight into the market, a wide range of segments have been covered in the report along with the thorough analysis of the key trends and the factors that impact the market. The main highlight of the report includes the key factors
Atipamezole Market Emerging Trends & Growing Popularity in upcoming year – Key …
Market Research Hub (MRH) has actively included a new research study titled Global Atipamezole Market Insights, Forecast to 2025 to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until forecast period limit; 2025. In
Atipamezole Market to face continuous growth by 2023 : Pfizer Inc., Orion Corpor …
Atipamezole is a synthetic alpha 2 adrenergic receptor antagonist drug, which reverses the effects of sedative and analgesic drugs such as medetomidine, xylazine, amitraz, and detomidine among others, in animals. In addition, it is used to treat amitraz and imidazoline decongestants toxicity in animals. Reduction in sedative time of animals shortens the in-clinic stay, saves the time of the staff, reduces hospitalization costs, and reduces revisits of the animal owner. Furthermore,